Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Immune Stimulation with Imiquimod to Best Face SARS-CoV-2 Infection and Prevent Long COVID.

  • Authors : Pacheco-García U; Department of Cardio-Renal Pathophysiology, Instituto Nacional de Cardiología 'Ignacio Chávez', Mexico City 14080, Mexico.; Varela-López E

Subjects: Imiquimod* ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 12; Vol. 25 (14). Date of Electronic Publication: 2024 Jul 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Mutual Inhibition of Antithrombin III and SARS-CoV-2 Cellular Attachment to Syndecans: Implications for COVID-19 Treatment and Vaccination.

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/metabolism ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/physiology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 09; Vol. 25 (14). Date of Electronic Publication: 2024 Jul 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Saliva Is a Sensitive and Accessible Sample Both for SARS-CoV-2 Detection and for the Evaluation of Treatment Effectiveness in Follow-Up Studies.

  • Authors : Lalle E; Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.; Mazzotta V

Subjects: Saliva*/Saliva*/Saliva*/virology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/isolation & purification ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects

  • Source: Viruses [Viruses] 2024 Jun 27; Vol. 16 (7). Date of Electronic Publication: 2024 Jun 27.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Development of Robust Freeze-Drying Process for Long-Term Stability of rVSV-SARS-CoV-2 Vaccine.

  • Authors : Khan MDFH; Viral Vectors and Vaccines Bioprocessing Group, Department of Bioengineering, McGill University, Montreal, QC H2X 1Y4, Canada.; Youssef M

Subjects: Freeze Drying*/Freeze Drying*/Freeze Drying*/methods ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/chemistry

  • Source: Viruses [Viruses] 2024 Jun 11; Vol. 16 (6). Date of Electronic Publication: 2024 Jun 11.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals.

  • Authors : de Souza Goncalves B; Department of Surgery, Internal Medicine and Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25701, USA.; Sangani D

Subjects: Dietary Supplements* ; COVID-19*/COVID-19*/COVID-19*/complications ; COVID-19*/COVID-19*/COVID-19*/virology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 03; Vol. 25 (15). Date of Electronic Publication: 2024 Aug 03.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Targeting Myeloid Differentiation Primary Response Protein 88 (MyD88) and Galectin-3 to Develop Broad-Spectrum Host-Mediated Therapeutics against SARS-CoV-2.

  • Authors : Saikh KU; GlycoMantra Inc., bwtech South of the University of Maryland Baltimore County, 1450 South Rolling Road, Baltimore, MD 21227, USA.; Anam K

Subjects: Myeloid Differentiation Factor 88*/Myeloid Differentiation Factor 88*/Myeloid Differentiation Factor 88*/metabolism ; Myeloid Differentiation Factor 88*/Myeloid Differentiation Factor 88*/Myeloid Differentiation Factor 88*/genetics ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/physiology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 01; Vol. 25 (15). Date of Electronic Publication: 2024 Aug 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

The Association of Genetic Markers Involved in Muscle Performance Responding to Lactate Levels during Physical Exercise Therapy by Nordic Walking in Patients with Long COVID Syndrome: A Nonrandomized Controlled Pilot Study.

Subjects: Exercise Therapy*/Exercise Therapy*/Exercise Therapy*/methods ; COVID-19*/COVID-19*/COVID-19*/genetics ; COVID-19*/COVID-19*/COVID-19*/therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 30; Vol. 25 (15). Date of Electronic Publication: 2024 Jul 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies.

  • Authors : Chung YS; Department of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.; Lam CY

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/virology SARS-CoV-2 variants

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 26; Vol. 25 (15). Date of Electronic Publication: 2024 Jul 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Clinical Spectrum of Long COVID: Effects on Female Reproductive Health.

  • Authors : Maham S; Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology, Gachon University, Incheon 21999, Republic of Korea.; Yoon MS

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/virology ; COVID-19*/COVID-19*/COVID-19*/immunology

  • Source: Viruses [Viruses] 2024 Jul 16; Vol. 16 (7). Date of Electronic Publication: 2024 Jul 16.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

The Evaluation of Drugs as Potential Modulators of the Trafficking and Maturation of ACE2, the SARS-CoV-2 Receptor.

  • Authors : Alkhofash NF; Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain P.O. Box 15551, United Arab Emirates.; Ali BR

Subjects: Angiotensin-Converting Enzyme 2*/Angiotensin-Converting Enzyme 2*/Angiotensin-Converting Enzyme 2*/metabolism ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/metabolism

  • Source: Biomolecules [Biomolecules] 2024 Jun 27; Vol. 14 (7). Date of Electronic Publication: 2024 Jun 27.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Comparative Analysis of the Clinical Presentation of Individuals Who Test Positive or Negative for SARS-CoV-2: Results from a Test Street Study.

  • Authors : Kiani P; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584CG Utrecht, The Netherlands.; Hendriksen PA

Subjects: COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/virology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/isolation & purificationSARS-CoV-2 variants

  • Source: Viruses [Viruses] 2024 Jun 26; Vol. 16 (7). Date of Electronic Publication: 2024 Jun 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Assessing the Potential of an Enzymatically Liberated Salmon Oil to Support Immune Health Recovery from Acute SARS-CoV-2 Infection via Change in the Expression of Cytokine, Chemokine and Interferon-Related Genes.

Subjects: Fish Oils*/Fish Oils*/Fish Oils*/pharmacology ; Fish Oils*/Fish Oils*/Fish Oils*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/immunology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 24; Vol. 25 (13). Date of Electronic Publication: 2024 Jun 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?

  • Authors : Fernández-de-Las-Peñas C; Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos, 28922 Madrid, Spain.; Center for Neuroplasticity and Pain (CNAP), Sensory-Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK 9220 Aalborg, Denmark.

Subjects: Alanine*/Alanine*/Alanine*/analogs & derivatives ; Alanine*/Alanine*/Alanine*/therapeutic use ; Alanine*/Alanine*/Alanine*/administration & dosage

  • Source: Viruses [Viruses] 2024 Jun 12; Vol. 16 (6). Date of Electronic Publication: 2024 Jun 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Molecular Research on Coronavirus: Pathogenic Mechanisms, Antiviral Drugs, and New Vaccines.

  • Authors : Zhang M; National Key Laboratory of Agricultural Microbiology, Hubei Hongshan Laboratory, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China.; Lang Y

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 04; Vol. 25 (11). Date of Electronic Publication: 2024 Jun 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Quadruplex Droplet Digital PCR Assay for Screening and Quantification of SARS-CoV-2.

  • Authors : Li R; Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.; Department of Neurosurgery, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, China.

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/isolation & purification ; COVID-19*/COVID-19*/COVID-19*/diagnosis

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 26; Vol. 25 (15). Date of Electronic Publication: 2024 Jul 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Recovering from COVID-19 (ReCOV): Feasibility of an Allied-Health-Led Multidisciplinary Outpatient Rehabilitation Service for People with Long COVID.

  • Authors : D'Souza AN; Allied Health, The Royal Melbourne Hospital, Parkvillle, VIC 3050, Australia.; Merrett M

Subjects: COVID-19*/COVID-19*/COVID-19*/rehabilitation ; Feasibility Studies*; Humans

  • Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2024 Jul 22; Vol. 21 (7). Date of Electronic Publication: 2024 Jul 22.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Antimalarial Drugs at the Intersection of SARS-CoV-2 and Rheumatic Diseases: What Are the Potential Opportunities?

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Antimalarials*/Antimalarials*/Antimalarials*/adverse effects ; COVID-19 Drug Treatment*

  • Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2024 Jul 19; Vol. 60 (7). Date of Electronic Publication: 2024 Jul 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

A Study Examining the Impact of County-Level Demographic, Socioeconomic, and Political Affiliation Characteristics on COVID-19 Vaccination Patterns in Indiana.

  • Authors : Pangan G; Department of Applied & Computational Mathematics & Statistics, University of Notre Dame, Notre Dame, IN 46556, USA.; Woodard V

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Socioeconomic Factors* ; Politics*

  • Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2024 Jul 09; Vol. 21 (7). Date of Electronic Publication: 2024 Jul 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Sex Modifies the Effect of COVID-19 on Arterial Elasticity.

  • Authors : Durieux JC; University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.; Zisis SN

Subjects: COVID-19*/COVID-19*/COVID-19*/physiopathology ; SARS-CoV-2*; Humans

  • Source: Viruses [Viruses] 2024 Jul 06; Vol. 16 (7). Date of Electronic Publication: 2024 Jul 06.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents.

  • Authors : Zagórska A; Department of Medicinal Chemistry, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland.; Czopek A

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/enzymology ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology

  • Source: Biomolecules [Biomolecules] 2024 Jul 04; Vol. 14 (7). Date of Electronic Publication: 2024 Jul 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

ct2vl : A Robust Public Resource for Converting SARS-CoV-2 Ct Values to Viral Loads.

  • Authors : Hill ED; Beth Israel Deaconess Medical Center, Division of Clinical Pathology, Department of Pathology, Boston, MA 02215, USA.; Yilmaz F

Subjects: Viral Load* ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; COVID-19*/COVID-19*/COVID-19*/virology

  • Source: Viruses [Viruses] 2024 Jun 30; Vol. 16 (7). Date of Electronic Publication: 2024 Jun 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions.

  • Authors : Padín JF; Department of Medical Sciences, School of Medicine at Ciudad Real, University of Castilla-La Mancha, 13971 Ciudad Real, Spain.; Pérez-Ortiz JM

Subjects: Aprotinin*/Aprotinin*/Aprotinin*/therapeutic use ; Aprotinin*/Aprotinin*/Aprotinin*/pharmacology ; Aprotinin*/Aprotinin*/Aprotinin*/chemistry

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 29; Vol. 25 (13). Date of Electronic Publication: 2024 Jun 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Influence of Environmental Risk Exposure on the Determinants of COVID-19 Booster Vaccination in an Urban Thai Population.

  • Authors : Ounsaneha W; Faculty of Science and Technology, Valaya Alongkorn Rajabhat University under the Royal Patronage Pathumthani Province, Klong Nuang, Klong Luang, Pathumthani 13180, Thailand.; Laosee O

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Environmental Exposure*/Environmental Exposure*/Environmental Exposure*/statistics & numerical data ; Immunization, Secondary*/Immunization, Secondary*/Immunization, Secondary*/statistics & numerical data

  • Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2024 Jun 06; Vol. 21 (6). Date of Electronic Publication: 2024 Jun 06.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Persistence of COVID-19 Symptoms and Quality of Life at Three and Twelve Months after Hospital Discharge.

  • Authors : Gutiérrez-Canales LG; General Directorate of Quality and Health Education, Ministry of Health, Ciudad de Mexico 11410, Mexico.; Department of Medicine, University of Guanajuato, León 37670, Guanajuato, Mexico.

Subjects: COVID-19*/COVID-19*/COVID-19*/psychology ; Quality of Life* ; Patient Discharge*

  • Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2024 Jun 05; Vol. 60 (6). Date of Electronic Publication: 2024 Jun 05.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants.

  • Authors : Cui L; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen 361102, China.; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China.

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; COVID-19*/COVID-19*/COVID-19*/immunology SARS-CoV-2 variants

  • Source: Viruses [Viruses] 2024 Jun 01; Vol. 16 (6). Date of Electronic Publication: 2024 Jun 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Inhibition of SARS-CoV-2 Nsp9 ssDNA-Binding Activity and Cytotoxic Effects on H838, H1975, and A549 Human Non-Small Cell Lung Cancer Cells: Exploring the Potential of Nepenthes miranda Leaf Extract for Pulmonary Disease Treatment.

  • Authors : Su HH; Department of Pharmacy, Chia Nan University of Pharmacy and Science, Tainan City 717, Taiwan.; Lin ES

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/metabolism ; COVID-19 Drug Treatment*

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 01; Vol. 25 (11). Date of Electronic Publication: 2024 Jun 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

A Natural Bioactive Peptide from Pinctada fucata Pearls Can Be Used as a Potential Inhibitor of the Interaction between SARS-CoV-2 and ACE2 against COVID-19.

  • Authors : Wang Y; Department of Biotechnology and Biomedicine, Yangtze Delta Region Institute of Tsinghua University, Jiaxing 314006, China.; Wang Q

Subjects: Angiotensin-Converting Enzyme 2*/Angiotensin-Converting Enzyme 2*/Angiotensin-Converting Enzyme 2*/metabolism ; Angiotensin-Converting Enzyme 2*/Angiotensin-Converting Enzyme 2*/Angiotensin-Converting Enzyme 2*/chemistry ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 19; Vol. 25 (14). Date of Electronic Publication: 2024 Jul 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Prevalence and Symptom Profile of Long COVID among Schoolchildren in Vietnam.

  • Authors : Vu TT; National Centre for Epidemiology and Population Health, Research School of Population Health, College of Health and Medicine, Australian National University, Canberra, ACT 2601, Australia.; Department of Communicable Disease Control, National Institute of Hygiene and Epidemiology, Hanoi 100000, Vietnam.

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; SARS-CoV-2* ; Quality of Life*

  • Source: Viruses [Viruses] 2024 Jun 25; Vol. 16 (7). Date of Electronic Publication: 2024 Jun 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Rational Approach toward COVID-19's Main Protease Inhibitors: A Hierarchical Biochemoinformatics Analysis.

  • Authors : Bastos RS; Graduate Program in Medicinal Chemistry and Molecular Modeling, Federal University of Pará, Belém 66075-110, PA, Brazil.; Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapa 68903-419, AP, Brazil.

Subjects: Molecular Docking Simulation* ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects ; Molecular Dynamics Simulation*

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 18; Vol. 25 (12). Date of Electronic Publication: 2024 Jun 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Rapid Determination of SARS-CoV-2 Integrity and Infectivity by Using Propidium Monoazide Coupled with Digital Droplet PCR.

  • Authors : Sberna G; Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases 'Lazzaro Spallanzani' (IRCCS), 00149 Rome, Italy.; Mija C

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/isolation & purification ; Azides*/Azides*/Azides*/chemistry

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 03; Vol. 25 (11). Date of Electronic Publication: 2024 Jun 03.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Discovery of Novel Spike Inhibitors against SARS-CoV-2 Infection.

  • Authors : Tai LT; Industrial Development Graduate Program of College of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu 300193, Taiwan.; Yeh CY

Subjects: Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/metabolism ; Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/chemistry ; Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/antagonists & inhibitors

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 01; Vol. 25 (11). Date of Electronic Publication: 2024 Jun 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

SPIKENET: An Evidence-Based Therapy for Long COVID.

  • Authors : Elumalai N; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA.; Hussain H

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects ; COVID-19*/COVID-19*/COVID-19*/therapy ; COVID-19*/COVID-19*/COVID-19*/virology

  • Source: Viruses [Viruses] 2024 May 24; Vol. 16 (6). Date of Electronic Publication: 2024 May 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance Panels.

  • Authors : Ray P; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, CA 92093, USA.; Ledgerwood-Lee M

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; Coronavirus Nucleocapsid Proteins*/Coronavirus Nucleocapsid Proteins*/Coronavirus Nucleocapsid Proteins*/immunology SARS-CoV-2 variants

  • Source: Viruses [Viruses] 2024 Apr 24; Vol. 16 (5). Date of Electronic Publication: 2024 Apr 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Targeting the High-Density Lipoprotein Proteome for the Treatment of Post-Acute Sequelae of SARS-CoV-2.

  • Authors : Grote K; Department of Cardiology, Angiology, and Intensive Care, Philipps University Marburg, 35043 Marburg, Germany.; Schaefer AC

Subjects: Proteome*/Proteome*/Proteome*/metabolism ; COVID-19*/COVID-19*/COVID-19*/blood ; COVID-19*/COVID-19*/COVID-19*/virology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 20; Vol. 25 (8). Date of Electronic Publication: 2024 Apr 20.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Hesperidin, a Potential Antiviral Agent against SARS-CoV-2: The Influence of Citrus Consumption on COVID-19 Incidence and Severity in China.

  • Authors : Kowalczyk A; Department of Pharmacognosy and Herbal Medicines, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wrocław, Poland.

Subjects: Hesperidin*/Hesperidin*/Hesperidin*/therapeutic use ; Citrus* ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use

  • Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2024 May 28; Vol. 60 (6). Date of Electronic Publication: 2024 May 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review.

  • Authors : Riou M; Translational Medicine Federation of Strasbourg (FMTS), University of Strasbourg, CRBS, Team 3072 'Mitochondria, Oxidative Stress and Muscle Protection', 1 rue Eugène Boeckel, CS 60026, 67084 Strasbourg, France.; Physiology and Functional Exploration Service, University Hospital of Strasbourg, 1 Place de l'hôpital, 67091 Strasbourg, France.

Subjects: COVID-19*/COVID-19*/COVID-19*/complications ; COVID-19*/COVID-19*/COVID-19*/virology ; COVID-19*/COVID-19*/COVID-19*/pathology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 30; Vol. 25 (9). Date of Electronic Publication: 2024 Apr 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Long-Term Impairment of Working Ability in Subjects under 60 Years of Age Hospitalised for COVID-19 at 2 Years of Follow-Up: A Cross-Sectional Study.

  • Authors : Frallonardo L; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Clinic of Infectious Diseases, University of Bari 'Aldo Moro', Piazza Giulio Cesare n. 11 Cap, 70124 Bari, Italy.; Ritacco AI

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/virology ; Hospitalization*/Hospitalization*/Hospitalization*/statistics & numerical data

  • Source: Viruses [Viruses] 2024 Apr 26; Vol. 16 (5). Date of Electronic Publication: 2024 Apr 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Rapid Nucleic Acid Diagnostic Technology for Pandemic Diseases.

  • Authors : Lei Y; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Chinese Academy of Sciences (CAS), Beijing 100190, China.; University of Chinese Academy of Sciences (UCAS), Beijing 100049, China.

Subjects: COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; Nucleic Acids*

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Mar 29; Vol. 29 (7). Date of Electronic Publication: 2024 Mar 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Exploring Factors Influencing COVID-19 Vaccine Hesitancy and Refusal: A Study in Italy during the Vaccine Rollout.

  • Authors : Barazzetti A; Department of Human and Social Sciences, University of Bergamo, 24129 Bergamo, Italy.; Milesi S

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2024 Mar 12; Vol. 21 (3). Date of Electronic Publication: 2024 Mar 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Antiviral Use in Mild-to-Moderate SARS-CoV-2 Infections during the Omicron Wave in Geriatric Patients.

  • Authors : Exquis N; Division of Clinical Pharmacology and Toxicology, Department of Anesthesiology, Pharmacology, Intensive Care, and Emergency Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.; Dionisi B

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/adverse effects ; COVID-19 Drug Treatment*

  • Source: Viruses [Viruses] 2024 May 28; Vol. 16 (6). Date of Electronic Publication: 2024 May 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response.

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/virology ; Epithelial Cells*/Epithelial Cells*/Epithelial Cells*/virology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 May 13; Vol. 25 (10). Date of Electronic Publication: 2024 May 13.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial.

  • Authors : Holubovska O; Department of Infectious Diseases, O.O. Bogomolets National Medical University, T. Shevchenko Blvd. 13, 01601 Kyiv, Ukraine.; Babich P

Subjects: COVID-19 Drug Treatment*; Humans ; Double-Blind Method

  • Source: Advances in respiratory medicine [Adv Respir Med] 2024 May 06; Vol. 92 (3), pp. 202-217. Date of Electronic Publication: 2024 May 06.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101697329 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Gut Microbiome and Cytokine Profiles in Post-COVID Syndrome.

  • Authors : Mussabay K; Department of Microbiology and Virology Named after Sh.I.Sarbasova, Astana Medical University, Astana 010000, Kazakhstan.; Kozhakhmetov S

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/microbiology ; COVID-19*/COVID-19*/COVID-19*/complications

  • Source: Viruses [Viruses] 2024 May 02; Vol. 16 (5). Date of Electronic Publication: 2024 May 02.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019.

  • Authors : Yamamoto C; Department of Infection Control and Laboratory Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.; Taniguchi M

Subjects: Immunocompromised Host* ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects

  • Source: Viruses [Viruses] 2024 Apr 30; Vol. 16 (5). Date of Electronic Publication: 2024 Apr 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies.

  • Authors : Guo H; IGM Biosciences, Mountain View, CA 94043, USA.; Ha S

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; Immune Evasion* SARS-CoV-2 variants

  • Source: Viruses [Viruses] 2024 Apr 28; Vol. 16 (5). Date of Electronic Publication: 2024 Apr 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Challenges in Treating Pediatric Cancer Patients during the COVID-19 Pandemic: Balancing Risks and Care.

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/therapy ; Neoplasms*/Neoplasms*/Neoplasms*/complications

  • Source: Viruses [Viruses] 2024 Apr 26; Vol. 16 (5). Date of Electronic Publication: 2024 Apr 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Wide Real-Life Data Support Reduced Sensitivity of Antigen Tests for Omicron SARS-CoV-2 Infections.

  • Authors : Piubelli C; Department of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore-Don Calabria Hospital, Negrar di Valpolicella, 37124 Verona, Italy.; Treggiari D

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; COVID-19*/COVID-19*/COVID-19*/diagnosis SARS-CoV-2 variants

  • Source: Viruses [Viruses] 2024 Apr 23; Vol. 16 (5). Date of Electronic Publication: 2024 Apr 23.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections.

  • Authors : Hurwitz SJ; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, 1760 Haygood Drive, Atlanta, GA 30322, USA.; De R

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Drug Repositioning*

  • Source: Viruses [Viruses] 2024 Apr 22; Vol. 16 (4). Date of Electronic Publication: 2024 Apr 22.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Development of Detection Antibody Targeting the Linear Epitope in SARS-CoV-2 Nucleocapsid Protein with Ultra-High Sensitivity.

  • Authors : Wu F; Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.; Shenzhen Institute of Drug Control, Shenzhen 518057, China.

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; Epitopes*/Epitopes*/Epitopes*/immunology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 18; Vol. 25 (8). Date of Electronic Publication: 2024 Apr 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Clinical Evaluation of the BIOFIRE SPOTFIRE Respiratory Panel.

  • Authors : Chan WS; Department of Pathology, Hong Kong Sanatorium & Hospital, Hong Kong SAR, China.; Ho CW

Subjects: COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/virology ; Respiratory Tract Infections*/Respiratory Tract Infections*/Respiratory Tract Infections*/virology

  • Source: Viruses [Viruses] 2024 Apr 13; Vol. 16 (4). Date of Electronic Publication: 2024 Apr 13.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium:

Record details

×
  • 1-50 of  50,921 results for ""COVID-19""